Literature DB >> 908337

Inhibition of cholesterol synthesis in vitro and in vivo by ML-236A and ML-236B, competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.

A Endo, Y Tsujita, M Kuroda, K Tanzawa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 908337     DOI: 10.1111/j.1432-1033.1977.tb11637.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


× No keyword cloud information.
  46 in total

1.  Pharmacokinetic and pharmacodynamic evaluation for tissue-selective inhibition of cholesterol synthesis by pravastatin.

Authors:  T Hatanaka; S Honda; S Sasaki; K Katayama; T Koizumi
Journal:  J Pharmacokinet Biopharm       Date:  1998-06

2.  Hypolipidemic effects in monkeys of ML-236B, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase.

Authors:  M Kuroda; Y Tsujita; K Tanzawa; A Endo
Journal:  Lipids       Date:  1979-06       Impact factor: 1.880

Review 3.  Statins and the role of nitric oxide in chronic heart failure.

Authors:  Stephan von Haehling; Stefan D Anker; Eberhard Bassenge
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

Review 4.  Statin therapy and plasma free fatty acids: a systematic review and meta-analysis of controlled clinical trials.

Authors:  Amirhossein Sahebkar; Luis E Simental-Mendía; Claudio Pedone; Gianna Ferretti; Petr Nachtigal; Simona Bo; Giuseppe Derosa; Pamela Maffioli; Gerald F Watts
Journal:  Br J Clin Pharmacol       Date:  2016-02-02       Impact factor: 4.335

Review 5.  The proteasome: a central regulator of inflammation and macrophage function.

Authors:  Nilofer Qureshi; Stefanie N Vogel; Charles Van Way; Christopher J Papasian; Asaf A Qureshi; David C Morrison
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

6.  Cholesterol synthesis in polyclonally activated cytotoxic lymphocytes and its requirement for differentiation and proliferation.

Authors:  H J Heiniger; J D Marshall
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

7.  Inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase by mevinolin in familial hypercholesterolemia heterozygotes: effects on cholesterol balance.

Authors:  S M Grundy; D W Bilheimer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes.

Authors:  D W Bilheimer; S M Grundy; M S Brown; J L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

9.  Novel simvastatin inhalation formulation and characterisation.

Authors:  Alaa S Tulbah; Hui Xin Ong; Paolo Colombo; Paul M Young; Daniela Traini
Journal:  AAPS PharmSciTech       Date:  2014-05-08       Impact factor: 3.246

10.  Combined therapy with probucol and pravastatin in hypercholesterolaemia. One year follow-up study.

Authors:  K Saku; B Zhang; K Hirata; Y Okura; H Bai; R Liu; K Arakawa
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.